Drug Design Development and Therapy · 2014 · 12 citations · 23 references
Our study demonstrated that a TAC-based primary immunosuppressive therapy is superior to a CSA-based immunosuppressive regimen in patients after HTX regarding time to first biopsy-proven rejection.
23
Susan Stewart, Michael C. Fishbein, Gregory I. Snell et al. · The Journal of Heart and Lung Transplantation · 2007 · 2.4K citations
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Henrik Ekberg, Hélio Tedesco‐Silva, A. Demirbaş et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text
Susan Stewart, Gayle L. Winters, Michael C. Fishbein et al. · The Journal of Heart and Lung Transplantation · 2005 · 1.7K citations
Heart Failure, Structural Heart Disease, Cardiovascular Disease +8